Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002402

Executive VP, CFO & COO bought 500 shares at an average $3.28 ($1,638)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Marvin Donald Executive VP, CFO & COO 2022-03-16 Purchase +250 $3.30 $825 1,750 D
Marvin Donald Executive VP, CFO & COO 2022-03-16 Purchase +250 $3.25 $813 2,000 D
Derivatives
Marvin Donald Executive VP, CFO & COO 2021-11-08 Grant or award · Option to Purchase American Depositary Shares +196,875 196,875 D
Open-market purchases · 500 sh · avg $3.28 · $1,638
Loading xslF345X03/ownership.xml…